dc.contributorUniversidade Estadual Paulista (UNESP)
dc.creatorSilva, M.
dc.creatorRicelli, N. L.
dc.creatorEl Seoud, O.
dc.creatorValentim, C. S.
dc.creatorFerreira, A. G.
dc.creatorSato, D. N.
dc.creatorLeitel, CQF
dc.creatorFerreira, E. I.
dc.date2014-05-20T13:24:28Z
dc.date2016-10-25T16:45:11Z
dc.date2014-05-20T13:24:28Z
dc.date2016-10-25T16:45:11Z
dc.date2006-06-01
dc.date.accessioned2017-04-05T20:00:15Z
dc.date.available2017-04-05T20:00:15Z
dc.identifierArchiv Der Pharmazie. Weinheim: Wiley-v C H Verlag Gmbh, v. 339, n. 6, p. 283-290, 2006.
dc.identifier0365-6233
dc.identifierhttp://hdl.handle.net/11449/7598
dc.identifierhttp://acervodigital.unesp.br/handle/11449/7598
dc.identifier10.1002/ardp.200500039
dc.identifierWOS:000238395100001
dc.identifierhttp://dx.doi.org/10.1002/ardp.200500039
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/856202
dc.descriptionPyrazinamide was condensed with the poly(ethylene glycol)-poly(aspartic acid) copolymer (PEG-PASP), a micelle-forming derivative was obtained that was characterized in terms of its critical micelle concentration (CMC) and micelle diameter. The CMC was found by observing the solubility of Sudan III in Poly(ethylene glycol)-poly(pyrazinamidomethyl aspartate) copolymer (PEG-PASP-PZA) solutions. The mean diameter of PEG-PASP-PZA micelles, obtained by analyzing the dynamic light-scattering data, was 78.2 nm. The PEG-PASP-PZA derivative, when assayed for anti-Mycobacterium activity, exhibited stronger activity than the simple drug.
dc.languageeng
dc.publisherWiley-Blackwell
dc.relationArchiv Der Pharmazie
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectpyrazinamide
dc.subjectmicelle-forming polymer
dc.subjecttuberculostatic prodrug
dc.titlePotential tuberculostatic agent: Micelle-forming pyrazinamide prodrug
dc.typeOtro


Este ítem pertenece a la siguiente institución